GlaxoSmithKline to spend $100M expanding Hamilton, Montana facility
Drugmaker GlaxoSmithKline has announced $100 million of new investment in its manufacturing site in Montana.
British-based GSK said in a statement released Wednesday that it will expand the production capacity at its Hamilton facility, where it produces components used in several of vaccines, including ones to help prevent malaria and shingles.
Sorry, we couldn't find any posts. Please try a different search.